PAIP1 Regulates Expression of Immune and Inflammatory Response Associated Genes at Transcript Level in Liver Cancer Cell

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2023 Apr 27

PMID 37101794

Authors

Jianfeng Zheng

Weiwei Fan

Xiaoyu Zhang

Weili Quan

Yunfei Wu

Mengni Shu

Moyang Chen

Ming Liang

Affiliations

Soon will be listed here.

Abstract

Poly(A) binding protein interacting protein 1 (PAIP1) is a translation regulator and also regulate the decay of mRNA. PAIP1 has also been reported to be a marker of increased invasive potential of liver cancer. However, the roles and underlying molecular mechanism of PAIP1 in liver cancer is still unclear. Here, cell viability and the gene expression profile of liver cancer line HepG2 transfected with PAIP1 siRNA was compared with cells transfected with non-targeting control siRNA. The results showed that PAIP1 knockdown inhibited cell viability, and extensively affects expression of 893 genes at transcriptional level in HepG2 cells. Gene function analysis showed that a large number of PAIP1 up-regulated genes were enriched in term of DNA-dependent transcription and the down-regulated genes were enriched in some pathways including immune response and inflammatory response. qPCR confirmed that PAIP1 knockdown positively regulated the expression of selected immune and inflammatory factor genes in HepG2 cells. Expression analysis of TCGA revealed that PAIP1 had positive correlations with two immune associated genes IL1R2 and PTAFR in liver tumor tissue. Taken together, our results demonstrated that PAIP1 was not only a translation regulator, but also a transcription regulator in liver cancer. Moreover, PAIP1 could function as a regulatory factor of immune and inflammatory genes in liver cancer. Thus, our study provides important cues for further study on the regulatory mechanism of PAIP1 in liver cancer.

References

Gebauer F, Schwarzl T, Valcarcel J, Hentze M . RNA-binding proteins in human genetic disease. Nat Rev Genet. 2020; 22(3):185-198. DOI: 10.1038/s41576-020-00302-y. View

Feng H, Liu J, Qiu Y, Liu Y, Saiyin H, Liang X . RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression. Oncogene. 2020; 39(33):5495-5506. DOI: 10.1038/s41388-020-1380-7. View

Llovet J, De Baere T, Kulik L, Haber P, Greten T, Meyer T . Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021; 18(5):293-313. DOI: 10.1038/s41575-020-00395-0. View

Keenan B, Fong L, Kelley R . Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. J Immunother Cancer. 2019; 7(1):267. PMC: 6798343. DOI: 10.1186/s40425-019-0749-z. View

Ma L, Hernandez M, Zhao Y, Mehta M, Tran B, Kelly M . Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer. Cancer Cell. 2019; 36(4):418-430.e6. PMC: 6801104. DOI: 10.1016/j.ccell.2019.08.007. View

Martineau Y, Wang X, Alain T, Petroulakis E, Shahbazian D, Fabre B . Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase. Mol Cell Biol. 2014; 34(6):1046-53. PMC: 3958023. DOI: 10.1128/MCB.01079-13. View

Li D, Jin L, Alesi G, Kim Y, Fan J, Seo J . The prometastatic ribosomal S6 kinase 2-cAMP response element-binding protein (RSK2-CREB) signaling pathway up-regulates the actin-binding protein fascin-1 to promote tumor metastasis. J Biol Chem. 2013; 288(45):32528-32538. PMC: 3820886. DOI: 10.1074/jbc.M113.500561. View

Yang Y, Liu F, Liu W, Ma M, Gao J, Lu Y . Analysis of single-cell RNAseq identifies transitional states of T cells associated with hepatocellular carcinoma. Clin Transl Med. 2020; 10(3):e133. PMC: 7418813. DOI: 10.1002/ctm2.133. View

Silva-Junior I, Dalmaso B, Herbster S, Lepique A, Jancar S . Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death. Front Oncol. 2018; 8:10. PMC: 5807395. DOI: 10.3389/fonc.2018.00010. View

10.

Xiao R, Chen J, Liang Z, Luo D, Chen G, Lu Z . Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription. Cell. 2019; 178(1):107-121.e18. PMC: 6760001. DOI: 10.1016/j.cell.2019.06.001. View

11.

Kim H, Jung W, Kim A, Kim H, Kim B . High Paip1 Expression as a Potential Prognostic Marker in Hepatocellular Carcinoma. In Vivo. 2020; 34(5):2491-2497. PMC: 7652522. DOI: 10.21873/invivo.12065. View

12.

Wang C, Zhu C, Xu J, Wang M, Zhao W, Liu Q . The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019; 18(1):115. PMC: 6609402. DOI: 10.1186/s12943-019-1032-0. View

13.

Guan H, Li N, Wang X, Shan X, Li Z, Lin Z . Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp Cell Res. 2019; 376(2):198-209. DOI: 10.1016/j.yexcr.2019.01.017. View

14.

Trapnell C, Williams B, Pertea G, Mortazavi A, Kwan G, van Baren M . Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010; 28(5):511-5. PMC: 3146043. DOI: 10.1038/nbt.1621. View

15.

Martineau Y, Derry M, Wang X, Yanagiya A, Berlanga J, Shyu A . Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol. 2008; 28(21):6658-67. PMC: 2573229. DOI: 10.1128/MCB.00738-08. View

16.

Munoz-Escobar J, Matta-Camacho E, Kozlov G, Gehring K . The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding. J Biol Chem. 2015; 290(37):22841-50. PMC: 4566254. DOI: 10.1074/jbc.M115.672246. View

17.

Grosset C, Chen C, Xu N, Sonenberg N, Jacquemin-Sablon H, Shyu A . A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell. 2000; 103(1):29-40. DOI: 10.1016/s0092-8674(00)00102-1. View

18.

Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X . RNA-binding proteins in tumor progression. J Hematol Oncol. 2020; 13(1):90. PMC: 7353687. DOI: 10.1186/s13045-020-00927-w. View

19.

Wang M, Huang S, Chen Z, Han Z, Li K, Chen C . Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma. BMC Cancer. 2020; 20(1):1136. PMC: 7684760. DOI: 10.1186/s12885-020-07625-3. View

20.

Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S . KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 2011; 39(Web Server issue):W316-22. PMC: 3125809. DOI: 10.1093/nar/gkr483. View